Patent · US Active

Thiazolyl-dihydro-quinazolines

US8354418B2 · kind B2 · utility

0Cited by

6References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Trixi Brandl · Warthausen, DE
Udo Maier · Senden, DE
Christoph Hoenke · Ingelheim am Rhein, DE
Anne T. Joergensen · Copenhagen, DK
Alexander Pautsch · Ulm, DE
Steffen Breitfelder · Aßmannshardt, DE
Matthias Grauert · Ingelheim am Rhein, DE
Matthias Hoffmann · Mittelbiberach, DE
Stefan Scheuerer · Warthausen, DE
Klaus Erb · Mittelbiberach, DE
Michael Pieper · Biberach, DE
Ingo Pragst · Marburg, DE

Key dates

Filing date	Jan 9, 2009
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Jul 1, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of general formula (I),wherein the groups A, R1, R2, Ra and Rb have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts, solvates and hydrates thereof, and processes for preparing these thiazolyl-dihydro-quinazolines and the use thereof as pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.